SCHEMBL6675280

SCHEMBL6675280

NC(=O)c1ccccc1OCC(O)CO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.61
LMNA P02545 3/20 0.61
AGTR1 P30556 1/20 0.61
KDM4E B2RXH2 4/20 0.57
HTT P42858 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
CYP2C19 P33261 1/20 0.54
PARP1 P09874 2/20 0.51
NR1I2 O75469 1/20 0.51
CHRM2 P08172 1/20 0.51
CYP3A4 P08684 1/20 0.51
ADRA2A P08913 1/20 0.51
MAPT P10636 1/20 0.51
OPRK1 P41145 1/20 0.51
HTR2B P41595 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
IRAK4 Q9NWZ3 1/20 0.50
KCNH2 Q12809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050989 0.85 CYP1A2 (0.58) CYP1A2LMNAAGTR1KDM4EHTT
SCHEMBL7492316 0.85 HTT (0.59) CYP1A2LMNAKDM4EHTTMEN1
SCHEMBL11631740 0.84 CYP1A2 (0.57) CYP1A2LMNAAGTR1KDM4EMEN1
SCHEMBL30151910 0.82 HTT (0.65) CYP1A2LMNAKDM4EHTTMEN1
SCHEMBL7754052 0.81 ABCB1 (0.69) CYP1A2LMNAAGTR1KDM4EABCB1
SCHEMBL26326254 0.80 CYP1A2 (0.81) CYP1A2LMNAAGTR1KDM4EHTT
SCHEMBL28229749 0.80 HTT (0.58) LMNAKDM4EHTTMEN1KMT2A
SCHEMBL13763533 0.80 HTT (0.71) LMNAKDM4EHTTMEN1KMT2A
SCHEMBL5692223 0.80 IRAK4 (0.43) CYP1A2LMNAAGTR1KDM4EHTT
SCHEMBL4862369 0.79 HTT (0.54) CYP1A2LMNAKDM4EHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004037159-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING FAT METABOLISM OBETHERAPY BIOTECHNOLOGY (FR) 2004-05-06 WO disclosed